Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation

Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), which is thought to result from immune-mediated inflammatory disorders, leads to high morbidity and health care cost. Fatty acid amide hydrolase (FAAH) is an enzyme crucially involved in the modulation...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Brain Behav Immun
Päätekijät: Shamran, Haidar, Singh, Narendra P., Zumbrun, Elizabeth E., Murphy, Angela, Taub, Dennis D., Mishra, Manoj K., Price, Robert L., Chatterjee, Saurabh, Nagarkatti, Mitzi, Nagarkatti, Prakash S., Singh, Udai P.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5154806/
https://ncbi.nlm.nih.gov/pubmed/27327245
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbi.2016.06.008
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia